---
$id: https://graph.org.ai/products/commodity/51372018
$type: Product
source: UNSPSC
code: "51372018"
title: "Nalfurafine"
class: "51372000"
classTitle: "Controlled substance analgesic morphinans"
family: "51370000"
familyTitle: "Controlled substance analgesics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Nalfurafine

**UNSPSC Code**: 51372018
**Class**: [Controlled substance analgesic morphinans](Controlled substance analgesic morphinans.mdx)
**Family**: [Controlled substance analgesics](../Controlled substance analgesics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an opioid receptor agonist with the molecular formula C28H32N2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier XC41AVD567, chemically known as (e)-n-(17-(cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6beta-yl)-3-(furan-3-yl)-n-methylprop-2-enamide but generally known as nalfurafine, which bears US NIH Compound Identifier 6445230. European Medicines Agency schedules Nalfurafine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25222. The term NALFURAFINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 17, No. 2, 2003, List 49). World Health Organization schedules nalfurafine in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule nalfurafine under HS 29391900 and SITC 54141. As of Q4 2014, NALFURAFINE remains the US FDA Preferred Term for this commodity. Nalfurafine bears US NLM identifiers UMLS ID C2825264 and NCI Concept Code C80585. SMILES: O1C2C34C(O)(C(N(CC3)CC3CC3)CC3C4C1C(O)CC3)CCC2N(C)C(=O)/C=C/C1CCOC1.

